nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—Amphetamine—Nateglinide—type 2 diabetes mellitus	0.17	0.337	CrCrCtD
Ephedrine—Dextroamphetamine—Nateglinide—type 2 diabetes mellitus	0.17	0.337	CrCrCtD
Ephedrine—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.165	0.327	CrCrCtD
Ephedrine—BCHE—Ramipril—type 2 diabetes mellitus	0.129	0.627	CbGbCtD
Ephedrine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.077	0.374	CbGbCtD
Ephedrine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.0025	0.295	CbGeAlD
Ephedrine—Etomidate—SLC2A1—type 2 diabetes mellitus	0.00213	0.365	CrCbGaD
Ephedrine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00168	0.198	CbGeAlD
Ephedrine—Amphetamine—CARTPT—type 2 diabetes mellitus	0.00131	0.224	CrCbGaD
Ephedrine—SLC6A2—nerve—type 2 diabetes mellitus	0.000946	0.112	CbGeAlD
Ephedrine—ACHE—islet of Langerhans—type 2 diabetes mellitus	0.000771	0.0909	CbGeAlD
Ephedrine—SLC18A2—adipose tissue—type 2 diabetes mellitus	0.000479	0.0565	CbGeAlD
Ephedrine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000445	0.00268	CcSEcCtD
Ephedrine—Angina pectoris—Losartan—type 2 diabetes mellitus	0.000445	0.00268	CcSEcCtD
Ephedrine—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000443	0.00266	CcSEcCtD
Ephedrine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.00044	0.00264	CcSEcCtD
Ephedrine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.00044	0.00264	CcSEcCtD
Ephedrine—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000439	0.00264	CcSEcCtD
Ephedrine—Nausea—Acarbose—type 2 diabetes mellitus	0.000436	0.00262	CcSEcCtD
Ephedrine—Pain—Glipizide—type 2 diabetes mellitus	0.000433	0.0026	CcSEcCtD
Ephedrine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000432	0.0026	CcSEcCtD
Ephedrine—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00043	0.00258	CcSEcCtD
Ephedrine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000427	0.00257	CcSEcCtD
Ephedrine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000426	0.00256	CcSEcCtD
Ephedrine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000421	0.00253	CcSEcCtD
Ephedrine—Tension—Gliclazide—type 2 diabetes mellitus	0.000421	0.00253	CcSEcCtD
Ephedrine—Nausea—Nateglinide—type 2 diabetes mellitus	0.00042	0.00252	CcSEcCtD
Ephedrine—Bradycardia—Metformin—type 2 diabetes mellitus	0.00042	0.00252	CcSEcCtD
Ephedrine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000417	0.00251	CcSEcCtD
Ephedrine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000416	0.0025	CcSEcCtD
Ephedrine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000416	0.0025	CcSEcCtD
Ephedrine—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000416	0.0025	CcSEcCtD
Ephedrine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000415	0.00249	CcSEcCtD
Ephedrine—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000415	0.00249	CcSEcCtD
Ephedrine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000411	0.00247	CcSEcCtD
Ephedrine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000409	0.00246	CcSEcCtD
Ephedrine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000406	0.00244	CcSEcCtD
Ephedrine—Pain—Sitagliptin—type 2 diabetes mellitus	0.000403	0.00242	CcSEcCtD
Ephedrine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000402	0.00241	CcSEcCtD
Ephedrine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.0004	0.0024	CcSEcCtD
Ephedrine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000396	0.00238	CcSEcCtD
Ephedrine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000394	0.00237	CcSEcCtD
Ephedrine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000393	0.00236	CcSEcCtD
Ephedrine—Sweating—Losartan—type 2 diabetes mellitus	0.000391	0.00235	CcSEcCtD
Ephedrine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000389	0.00234	CcSEcCtD
Ephedrine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000389	0.00234	CcSEcCtD
Ephedrine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000388	0.00233	CcSEcCtD
Ephedrine—Rash—Repaglinide—type 2 diabetes mellitus	0.000386	0.00232	CcSEcCtD
Ephedrine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000386	0.00232	CcSEcCtD
Ephedrine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000386	0.00232	CcSEcCtD
Ephedrine—Headache—Repaglinide—type 2 diabetes mellitus	0.000383	0.0023	CcSEcCtD
Ephedrine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000383	0.0023	CcSEcCtD
Ephedrine—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000382	0.00229	CcSEcCtD
Ephedrine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00038	0.00228	CcSEcCtD
Ephedrine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000379	0.00228	CcSEcCtD
Ephedrine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000379	0.00228	CcSEcCtD
Ephedrine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000377	0.00226	CcSEcCtD
Ephedrine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000375	0.00225	CcSEcCtD
Ephedrine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000374	0.00225	CcSEcCtD
Ephedrine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000371	0.00223	CcSEcCtD
Ephedrine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000371	0.00223	CcSEcCtD
Ephedrine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00037	0.00222	CcSEcCtD
Ephedrine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000365	0.00219	CcSEcCtD
Ephedrine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000365	0.00219	CcSEcCtD
Ephedrine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000364	0.00219	CcSEcCtD
Ephedrine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000364	0.00219	CcSEcCtD
Ephedrine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000364	0.00218	CcSEcCtD
Ephedrine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000363	0.00218	CcSEcCtD
Ephedrine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000362	0.00218	CcSEcCtD
Ephedrine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000354	0.00213	CcSEcCtD
Ephedrine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000353	0.00212	CcSEcCtD
Ephedrine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000351	0.00211	CcSEcCtD
Ephedrine—Vertigo—Orlistat—type 2 diabetes mellitus	0.00035	0.0021	CcSEcCtD
Ephedrine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000348	0.00209	CcSEcCtD
Ephedrine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000348	0.00209	CcSEcCtD
Ephedrine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000347	0.00209	CcSEcCtD
Ephedrine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000347	0.00209	CcSEcCtD
Ephedrine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000345	0.00207	CcSEcCtD
Ephedrine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000344	0.00207	CcSEcCtD
Ephedrine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000344	0.00206	CcSEcCtD
Ephedrine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000343	0.00206	CcSEcCtD
Ephedrine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000342	0.00205	CcSEcCtD
Ephedrine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000339	0.00204	CcSEcCtD
Ephedrine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000339	0.00204	CcSEcCtD
Ephedrine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000338	0.00203	CcSEcCtD
Ephedrine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000338	0.00203	CcSEcCtD
Ephedrine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000337	0.00202	CcSEcCtD
Ephedrine—Tremor—Metformin—type 2 diabetes mellitus	0.000336	0.00202	CcSEcCtD
Ephedrine—SLC18A2—liver—type 2 diabetes mellitus	0.000336	0.0396	CbGeAlD
Ephedrine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000335	0.00201	CcSEcCtD
Ephedrine—Sweating—Ramipril—type 2 diabetes mellitus	0.000335	0.00201	CcSEcCtD
Ephedrine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000335	0.00201	CcSEcCtD
Ephedrine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000334	0.00201	CcSEcCtD
Ephedrine—Tension—Irbesartan—type 2 diabetes mellitus	0.000332	0.002	CcSEcCtD
Ephedrine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000331	0.00199	CcSEcCtD
Ephedrine—Anxiety—Orlistat—type 2 diabetes mellitus	0.00033	0.00198	CcSEcCtD
Ephedrine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000329	0.00198	CcSEcCtD
Ephedrine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000327	0.00196	CcSEcCtD
Ephedrine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000325	0.00196	CcSEcCtD
Ephedrine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000322	0.00193	CcSEcCtD
Ephedrine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000321	0.00193	CcSEcCtD
Ephedrine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000321	0.00193	CcSEcCtD
Ephedrine—Rash—Glipizide—type 2 diabetes mellitus	0.000319	0.00192	CcSEcCtD
Ephedrine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000319	0.00192	CcSEcCtD
Ephedrine—Headache—Glipizide—type 2 diabetes mellitus	0.000317	0.00191	CcSEcCtD
Ephedrine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000317	0.00191	CcSEcCtD
Ephedrine—Palpitations—Metformin—type 2 diabetes mellitus	0.000317	0.0019	CcSEcCtD
Ephedrine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000316	0.0019	CcSEcCtD
Ephedrine—Tension—Losartan—type 2 diabetes mellitus	0.000313	0.00188	CcSEcCtD
Ephedrine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000312	0.00188	CcSEcCtD
Ephedrine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000312	0.00187	CcSEcCtD
Ephedrine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000311	0.00187	CcSEcCtD
Ephedrine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000311	0.00187	CcSEcCtD
Ephedrine—Hypertension—Metformin—type 2 diabetes mellitus	0.00031	0.00186	CcSEcCtD
Ephedrine—Nervousness—Losartan—type 2 diabetes mellitus	0.000309	0.00186	CcSEcCtD
Ephedrine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000308	0.0363	CbGeAlD
Ephedrine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000308	0.00185	CcSEcCtD
Ephedrine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000307	0.00184	CcSEcCtD
Ephedrine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000306	0.00184	CcSEcCtD
Ephedrine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000306	0.00184	CcSEcCtD
Ephedrine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00184	CcSEcCtD
Ephedrine—Chest pain—Metformin—type 2 diabetes mellitus	0.000305	0.00183	CcSEcCtD
Ephedrine—BCHE—nephron tubule—type 2 diabetes mellitus	0.000305	0.036	CbGeAlD
Ephedrine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000304	0.00183	CcSEcCtD
Ephedrine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000304	0.00183	CcSEcCtD
Ephedrine—Nausea—Glipizide—type 2 diabetes mellitus	0.000301	0.00181	CcSEcCtD
Ephedrine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.0003	0.0018	CcSEcCtD
Ephedrine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000299	0.0018	CcSEcCtD
Ephedrine—Pain—Gliclazide—type 2 diabetes mellitus	0.000299	0.0018	CcSEcCtD
Ephedrine—Tremor—Losartan—type 2 diabetes mellitus	0.000298	0.00179	CcSEcCtD
Ephedrine—Rash—Glimepiride—type 2 diabetes mellitus	0.000298	0.00179	CcSEcCtD
Ephedrine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000298	0.00179	CcSEcCtD
Ephedrine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000297	0.00178	CcSEcCtD
Ephedrine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000297	0.00178	CcSEcCtD
Ephedrine—Headache—Glimepiride—type 2 diabetes mellitus	0.000296	0.00178	CcSEcCtD
Ephedrine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000295	0.00177	CcSEcCtD
Ephedrine—Agitation—Losartan—type 2 diabetes mellitus	0.000293	0.00176	CcSEcCtD
Ephedrine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000292	0.00176	CcSEcCtD
Ephedrine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000291	0.00175	CcSEcCtD
Ephedrine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000288	0.00173	CcSEcCtD
Ephedrine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000288	0.00173	CcSEcCtD
Ephedrine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000287	0.00173	CcSEcCtD
Ephedrine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000287	0.00173	CcSEcCtD
Ephedrine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000287	0.00172	CcSEcCtD
Ephedrine—Vertigo—Losartan—type 2 diabetes mellitus	0.000286	0.00172	CcSEcCtD
Ephedrine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000283	0.0017	CcSEcCtD
Ephedrine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000283	0.0017	CcSEcCtD
Ephedrine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000282	0.00169	CcSEcCtD
Ephedrine—Palpitations—Losartan—type 2 diabetes mellitus	0.000282	0.00169	CcSEcCtD
Ephedrine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000281	0.00169	CcSEcCtD
Ephedrine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00028	0.00168	CcSEcCtD
Ephedrine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00028	0.00168	CcSEcCtD
Ephedrine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00028	0.00168	CcSEcCtD
Ephedrine—Asthenia—Glyburide—type 2 diabetes mellitus	0.00028	0.00168	CcSEcCtD
Ephedrine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000279	0.00168	CcSEcCtD
Ephedrine—Anorexia—Metformin—type 2 diabetes mellitus	0.000279	0.00168	CcSEcCtD
Ephedrine—Phenylpropanolamine—ADRA2A—type 2 diabetes mellitus	0.000278	0.0477	CrCbGaD
Ephedrine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000277	0.00166	CcSEcCtD
Ephedrine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000276	0.00166	CcSEcCtD
Ephedrine—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000274	0.0323	CbGeAlD
Ephedrine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000272	0.0321	CbGeAlD
Ephedrine—Pain—Orlistat—type 2 diabetes mellitus	0.000272	0.00163	CcSEcCtD
Ephedrine—Chest pain—Losartan—type 2 diabetes mellitus	0.000271	0.00163	CcSEcCtD
Ephedrine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000271	0.00163	CcSEcCtD
Ephedrine—Anxiety—Losartan—type 2 diabetes mellitus	0.00027	0.00162	CcSEcCtD
Ephedrine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00027	0.00162	CcSEcCtD
Ephedrine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00161	CcSEcCtD
Ephedrine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00161	CcSEcCtD
Ephedrine—Tension—Ramipril—type 2 diabetes mellitus	0.000268	0.00161	CcSEcCtD
Ephedrine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000267	0.0016	CcSEcCtD
Ephedrine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000267	0.0016	CcSEcCtD
Ephedrine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000265	0.00159	CcSEcCtD
Ephedrine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000263	0.00158	CcSEcCtD
Ephedrine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000263	0.00158	CcSEcCtD
Ephedrine—Confusional state—Losartan—type 2 diabetes mellitus	0.000262	0.00157	CcSEcCtD
Ephedrine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000262	0.00157	CcSEcCtD
Ephedrine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000261	0.00157	CcSEcCtD
Ephedrine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000258	0.00155	CcSEcCtD
Ephedrine—Tremor—Ramipril—type 2 diabetes mellitus	0.000256	0.00154	CcSEcCtD
Ephedrine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000255	0.00153	CcSEcCtD
Ephedrine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000254	0.00152	CcSEcCtD
Ephedrine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000253	0.00152	CcSEcCtD
Ephedrine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000251	0.00151	CcSEcCtD
Ephedrine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000251	0.00151	CcSEcCtD
Ephedrine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000251	0.00151	CcSEcCtD
Ephedrine—Agitation—Ramipril—type 2 diabetes mellitus	0.000251	0.00151	CcSEcCtD
Ephedrine—Anorexia—Losartan—type 2 diabetes mellitus	0.000248	0.00149	CcSEcCtD
Ephedrine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000248	0.00149	CcSEcCtD
Ephedrine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000246	0.00148	CcSEcCtD
Ephedrine—Rash—Glyburide—type 2 diabetes mellitus	0.000246	0.00148	CcSEcCtD
Ephedrine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000245	0.00147	CcSEcCtD
Ephedrine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000245	0.00147	CcSEcCtD
Ephedrine—Headache—Glyburide—type 2 diabetes mellitus	0.000244	0.00147	CcSEcCtD
Ephedrine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000243	0.00146	CcSEcCtD
Ephedrine—BCHE—adipose tissue—type 2 diabetes mellitus	0.000242	0.0285	CbGeAlD
Ephedrine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000241	0.00145	CcSEcCtD
Ephedrine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000241	0.00145	CcSEcCtD
Ephedrine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00024	0.00144	CcSEcCtD
Ephedrine—Pain—Irbesartan—type 2 diabetes mellitus	0.000236	0.00142	CcSEcCtD
Ephedrine—Insomnia—Losartan—type 2 diabetes mellitus	0.000235	0.00141	CcSEcCtD
Ephedrine—Pseudoephedrine—ADRA2A—type 2 diabetes mellitus	0.000235	0.0403	CrCbGaD
Ephedrine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000233	0.0014	CcSEcCtD
Ephedrine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000232	0.00139	CcSEcCtD
Ephedrine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000232	0.00139	CcSEcCtD
Ephedrine—Nausea—Glyburide—type 2 diabetes mellitus	0.000231	0.00139	CcSEcCtD
Ephedrine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000231	0.00139	CcSEcCtD
Ephedrine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000231	0.00139	CcSEcCtD
Ephedrine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000229	0.00137	CcSEcCtD
Ephedrine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000228	0.00137	CcSEcCtD
Ephedrine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000228	0.00137	CcSEcCtD
Ephedrine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000226	0.00136	CcSEcCtD
Ephedrine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000225	0.00135	CcSEcCtD
Ephedrine—Pseudoephedrine—TNF—type 2 diabetes mellitus	0.000223	0.0382	CrCbGaD
Ephedrine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000222	0.00134	CcSEcCtD
Ephedrine—Pain—Losartan—type 2 diabetes mellitus	0.000222	0.00134	CcSEcCtD
Ephedrine—Rash—Gliclazide—type 2 diabetes mellitus	0.000221	0.00133	CcSEcCtD
Ephedrine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00022	0.00132	CcSEcCtD
Ephedrine—Headache—Gliclazide—type 2 diabetes mellitus	0.000219	0.00132	CcSEcCtD
Ephedrine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000218	0.00131	CcSEcCtD
Ephedrine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000218	0.00131	CcSEcCtD
Ephedrine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000216	0.00129	CcSEcCtD
Ephedrine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000214	0.00129	CcSEcCtD
Ephedrine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000213	0.00128	CcSEcCtD
Ephedrine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000213	0.00128	CcSEcCtD
Ephedrine—Dizziness—Orlistat—type 2 diabetes mellitus	0.00021	0.00126	CcSEcCtD
Ephedrine—Asthenia—Metformin—type 2 diabetes mellitus	0.00021	0.00126	CcSEcCtD
Ephedrine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000208	0.00125	CcSEcCtD
Ephedrine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000206	0.00123	CcSEcCtD
Ephedrine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000204	0.00123	CcSEcCtD
Ephedrine—Rash—Valsartan—type 2 diabetes mellitus	0.000203	0.00122	CcSEcCtD
Ephedrine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000203	0.00122	CcSEcCtD
Ephedrine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000202	0.00121	CcSEcCtD
Ephedrine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000202	0.00121	CcSEcCtD
Ephedrine—Headache—Valsartan—type 2 diabetes mellitus	0.000201	0.00121	CcSEcCtD
Ephedrine—Rash—Orlistat—type 2 diabetes mellitus	0.0002	0.0012	CcSEcCtD
Ephedrine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.0002	0.0012	CcSEcCtD
Ephedrine—Headache—Orlistat—type 2 diabetes mellitus	0.000199	0.0012	CcSEcCtD
Ephedrine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000199	0.00119	CcSEcCtD
Ephedrine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000198	0.00119	CcSEcCtD
Ephedrine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000196	0.00118	CcSEcCtD
Ephedrine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000194	0.00116	CcSEcCtD
Ephedrine—Dizziness—Metformin—type 2 diabetes mellitus	0.000194	0.00116	CcSEcCtD
Ephedrine—Phenylpropanolamine—CYP1A2—type 2 diabetes mellitus	0.000193	0.0331	CrCbGaD
Ephedrine—Nausea—Valsartan—type 2 diabetes mellitus	0.000191	0.00115	CcSEcCtD
Ephedrine—ADRA1A—liver—type 2 diabetes mellitus	0.000191	0.0225	CbGeAlD
Ephedrine—Nausea—Orlistat—type 2 diabetes mellitus	0.000189	0.00113	CcSEcCtD
Ephedrine—Asthenia—Losartan—type 2 diabetes mellitus	0.000187	0.00112	CcSEcCtD
Ephedrine—Vomiting—Metformin—type 2 diabetes mellitus	0.000186	0.00112	CcSEcCtD
Ephedrine—Rash—Metformin—type 2 diabetes mellitus	0.000185	0.00111	CcSEcCtD
Ephedrine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000184	0.00111	CcSEcCtD
Ephedrine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000184	0.0011	CcSEcCtD
Ephedrine—Headache—Metformin—type 2 diabetes mellitus	0.000183	0.0011	CcSEcCtD
Ephedrine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000183	0.0011	CcSEcCtD
Ephedrine—Methamphetamine—ADRA2A—type 2 diabetes mellitus	0.000177	0.0303	CrCbGaD
Ephedrine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000176	0.00106	CcSEcCtD
Ephedrine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000176	0.00106	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP2E1—type 2 diabetes mellitus	0.000175	0.0299	CrCbGaD
Ephedrine—Rash—Irbesartan—type 2 diabetes mellitus	0.000174	0.00105	CcSEcCtD
Ephedrine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000174	0.00105	CcSEcCtD
Ephedrine—Nausea—Metformin—type 2 diabetes mellitus	0.000174	0.00104	CcSEcCtD
Ephedrine—Headache—Irbesartan—type 2 diabetes mellitus	0.000173	0.00104	CcSEcCtD
Ephedrine—Phentermine—CYP1A2—type 2 diabetes mellitus	0.000172	0.0295	CrCbGaD
Ephedrine—Dizziness—Losartan—type 2 diabetes mellitus	0.000172	0.00103	CcSEcCtD
Ephedrine—BCHE—liver—type 2 diabetes mellitus	0.000169	0.02	CbGeAlD
Ephedrine—Selegiline—CYP2E1—type 2 diabetes mellitus	0.000168	0.0287	CrCbGaD
Ephedrine—Benzyl alcohol—CYP1A2—type 2 diabetes mellitus	0.000166	0.0285	CrCbGaD
Ephedrine—Vomiting—Losartan—type 2 diabetes mellitus	0.000165	0.000993	CcSEcCtD
Ephedrine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000164	0.000986	CcSEcCtD
Ephedrine—Rash—Losartan—type 2 diabetes mellitus	0.000164	0.000985	CcSEcCtD
Ephedrine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000164	0.000984	CcSEcCtD
Ephedrine—Headache—Losartan—type 2 diabetes mellitus	0.000163	0.000979	CcSEcCtD
Ephedrine—Atomoxetine—HTR2C—type 2 diabetes mellitus	0.00016	0.0274	CrCbGaD
Ephedrine—Asthenia—Ramipril—type 2 diabetes mellitus	0.00016	0.000961	CcSEcCtD
Ephedrine—Selegiline—CYP1A2—type 2 diabetes mellitus	0.000159	0.0273	CrCbGaD
Ephedrine—Nausea—Losartan—type 2 diabetes mellitus	0.000154	0.000928	CcSEcCtD
Ephedrine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000147	0.000886	CcSEcCtD
Ephedrine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000142	0.000852	CcSEcCtD
Ephedrine—Rash—Ramipril—type 2 diabetes mellitus	0.000141	0.000844	CcSEcCtD
Ephedrine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00014	0.000844	CcSEcCtD
Ephedrine—Headache—Ramipril—type 2 diabetes mellitus	0.00014	0.000839	CcSEcCtD
Ephedrine—Nausea—Ramipril—type 2 diabetes mellitus	0.000132	0.000796	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP3A4—type 2 diabetes mellitus	0.00011	0.0188	CrCbGaD
Ephedrine—Selegiline—CYP3A4—type 2 diabetes mellitus	0.000106	0.0181	CrCbGaD
Ephedrine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	8e-05	0.0137	CrCbGaD
Ephedrine—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	1.97e-05	0.000182	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	1.96e-05	0.00018	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC2A4—type 2 diabetes mellitus	1.96e-05	0.00018	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GCG—type 2 diabetes mellitus	1.96e-05	0.00018	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.95e-05	0.00018	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.93e-05	0.000178	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.93e-05	0.000178	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.93e-05	0.000178	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TLE4—type 2 diabetes mellitus	1.93e-05	0.000178	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.93e-05	0.000178	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.93e-05	0.000178	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.92e-05	0.000177	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	1.92e-05	0.000177	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	1.9e-05	0.000175	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.9e-05	0.000175	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GCG—type 2 diabetes mellitus	1.87e-05	0.000173	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	1.87e-05	0.000172	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRB3—type 2 diabetes mellitus	1.86e-05	0.000171	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	1.84e-05	0.00017	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	1.84e-05	0.00017	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	1.84e-05	0.00017	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.83e-05	0.000169	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	1.82e-05	0.000168	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	1.82e-05	0.000168	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.8e-05	0.000166	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.79e-05	0.000165	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	1.78e-05	0.000164	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	1.77e-05	0.000164	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.77e-05	0.000163	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.76e-05	0.000163	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	1.76e-05	0.000162	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GCG—type 2 diabetes mellitus	1.74e-05	0.000161	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	1.74e-05	0.000161	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.74e-05	0.000161	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.72e-05	0.000159	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.71e-05	0.000158	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	1.7e-05	0.000157	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.69e-05	0.000155	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GNB3—type 2 diabetes mellitus	1.69e-05	0.000155	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—HMOX1—type 2 diabetes mellitus	1.68e-05	0.000155	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.68e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.67e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	1.67e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.67e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.66e-05	0.000153	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAT—type 2 diabetes mellitus	1.66e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.65e-05	0.000152	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.64e-05	0.000151	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.64e-05	0.000151	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.64e-05	0.000151	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.62e-05	0.000149	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOB—type 2 diabetes mellitus	1.61e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	1.6e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.6e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.6e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.59e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.59e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.59e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	1.59e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.59e-05	0.000146	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.57e-05	0.000145	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTM1—type 2 diabetes mellitus	1.56e-05	0.000144	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.55e-05	0.000143	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.54e-05	0.000142	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.54e-05	0.000142	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—LPL—type 2 diabetes mellitus	1.53e-05	0.000141	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.52e-05	0.00014	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.52e-05	0.00014	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.5e-05	0.000139	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	1.5e-05	0.000139	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.5e-05	0.000138	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ADCY5—type 2 diabetes mellitus	1.5e-05	0.000138	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPX1—type 2 diabetes mellitus	1.5e-05	0.000138	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	1.5e-05	0.000138	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.5e-05	0.000138	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.5e-05	0.000138	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.49e-05	0.000138	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAT—type 2 diabetes mellitus	1.48e-05	0.000136	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.47e-05	0.000136	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.46e-05	0.000135	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.46e-05	0.000135	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.46e-05	0.000134	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CD36—type 2 diabetes mellitus	1.46e-05	0.000134	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.45e-05	0.000133	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.44e-05	0.000133	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPP2CA—type 2 diabetes mellitus	1.44e-05	0.000133	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOB—type 2 diabetes mellitus	1.43e-05	0.000132	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.42e-05	0.000131	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.42e-05	0.00013	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—INSR—type 2 diabetes mellitus	1.41e-05	0.00013	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.41e-05	0.00013	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	1.39e-05	0.000129	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.39e-05	0.000128	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.38e-05	0.000127	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—type 2 diabetes mellitus	1.38e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.38e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.37e-05	0.000127	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—LPL—type 2 diabetes mellitus	1.37e-05	0.000126	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.36e-05	0.000126	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.36e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.36e-05	0.000125	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARA—type 2 diabetes mellitus	1.36e-05	0.000125	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	1.34e-05	0.000124	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.34e-05	0.000123	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.34e-05	0.000123	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	1.34e-05	0.000123	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—C3—type 2 diabetes mellitus	1.32e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.32e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.32e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.31e-05	0.000121	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AGT—type 2 diabetes mellitus	1.31e-05	0.000121	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CD36—type 2 diabetes mellitus	1.3e-05	0.00012	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CALM1—type 2 diabetes mellitus	1.29e-05	0.000119	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOE—type 2 diabetes mellitus	1.29e-05	0.000119	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	1.28e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.28e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.28e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.28e-05	0.000118	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	1.27e-05	0.000117	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.26e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.25e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.24e-05	0.000115	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.24e-05	0.000114	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.24e-05	0.000114	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	1.23e-05	0.000114	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.23e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.23e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.22e-05	0.000112	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.21e-05	0.000112	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.21e-05	0.000112	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	1.21e-05	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.2e-05	0.00011	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AGT—type 2 diabetes mellitus	1.17e-05	0.000108	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.16e-05	0.000107	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.16e-05	0.000107	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.15e-05	0.000106	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	1.15e-05	0.000106	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOE—type 2 diabetes mellitus	1.15e-05	0.000106	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.14e-05	0.000105	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.14e-05	0.000105	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	1.13e-05	0.000105	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.13e-05	0.000104	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.13e-05	0.000104	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.13e-05	0.000104	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.12e-05	0.000103	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	1.12e-05	0.000103	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.12e-05	0.000103	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.11e-05	0.000102	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.11e-05	0.000102	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.1e-05	0.000101	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—INS—type 2 diabetes mellitus	1.1e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.1e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.09e-05	0.0001	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.09e-05	0.0001	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.08e-05	9.98e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.05e-05	9.68e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.04e-05	9.55e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.03e-05	9.48e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.02e-05	9.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.02e-05	9.38e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—type 2 diabetes mellitus	1.01e-05	9.28e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	9.99e-06	9.21e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.86e-06	9.09e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—INS—type 2 diabetes mellitus	9.8e-06	9.03e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.68e-06	8.92e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.64e-06	8.88e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	9.63e-06	8.88e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	9.63e-06	8.88e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.55e-06	8.8e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	9.46e-06	8.72e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	9.42e-06	8.68e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.42e-06	8.68e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.38e-06	8.64e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.34e-06	8.6e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.24e-06	8.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	9.1e-06	8.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.07e-06	8.36e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.02e-06	8.32e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	9e-06	8.3e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	8.99e-06	8.29e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—type 2 diabetes mellitus	8.99e-06	8.28e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.96e-06	8.26e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.84e-06	8.15e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	8.81e-06	8.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	8.81e-06	8.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	8.81e-06	8.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.71e-06	8.03e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	8.69e-06	8.01e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	8.59e-06	7.92e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	8.59e-06	7.92e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.51e-06	7.84e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.31e-06	7.66e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.15e-06	7.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.01e-06	7.38e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	7.86e-06	7.25e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.86e-06	7.24e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	7.83e-06	7.21e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	7.52e-06	6.94e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.46e-06	6.88e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.44e-06	6.86e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	7.44e-06	6.85e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.4e-06	6.82e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.31e-06	6.74e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	7.29e-06	6.71e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	7.29e-06	6.71e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.28e-06	6.71e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.27e-06	6.7e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.24e-06	6.67e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.2e-06	6.64e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.91e-06	6.37e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.87e-06	6.33e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.6e-06	6.08e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.6e-06	6.08e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.5e-06	5.99e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	6.22e-06	5.74e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.21e-06	5.72e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.12e-06	5.64e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.02e-06	5.55e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.02e-06	5.54e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.99e-06	5.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.72e-06	5.27e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.65e-06	5.21e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.6e-06	5.16e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.57e-06	5.13e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.46e-06	5.03e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.46e-06	5.03e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.29e-06	4.88e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.24e-06	4.83e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.14e-06	4.74e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.13e-06	4.73e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.88e-06	4.5e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.75e-06	4.38e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.68e-06	4.31e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.63e-06	4.27e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.6e-06	4.24e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	4.43e-06	4.08e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.38e-06	4.04e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.36e-06	4.02e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.33e-06	3.99e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.28e-06	3.94e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.25e-06	3.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.04e-06	3.72e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	3.95e-06	3.64e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.93e-06	3.62e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.61e-06	3.33e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.54e-06	3.26e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.29e-06	3.03e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.03e-06	2.8e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.72e-06	2.51e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.51e-06	2.31e-05	CbGpPWpGaD
